全球霍亂疫苗市場：按產品類型、按疫苗類型、按患者類型、按分銷管道、按地區

全球霍亂疫苗市場預計2023年將達到8,250萬美元，2031年將達到2.046億美元，2024年至2031年年複合成長率為12%。

圖 1.2023年霍亂疫苗全球市場佔有率（依地區分類）

霍亂是一種細菌性疾病，通常透過受污染的水傳播。它會導致嚴重腹瀉和脫水，如果不及時治療，可能會在幾小時內導致死亡。這種疾病在水處理不足、環境衛生和衛生條件不佳的地區最為流行，例如非洲、東南亞和海地。世界衛生組織（WHO）和聯合國兒童基金會（UNICEF）警告說，霍亂捲土重來，特別是針對弱勢社區。當貧窮、戰爭或自然災害迫使人們生活在擁擠且缺乏足夠衛生設施的環境中時，霍亂爆發的風險最大。霍亂是一種貧困疾病，影響著無法獲得安全用水和基本衛生設施的人。霍亂不會直接在人與人之間傳播，因此與感染者的偶然接觸並不是患上這種疾病的主要危險因子。從預防的角度來看，採取多方面的方法對於控制霍亂和減少死亡非常重要。這包括獲得安全用水、適當的環境衛生和個人衛生以及在高風險地區接種疫苗。

市場動態：

推動全球霍亂疫苗市場成長的主要因素包括全球霍亂疾病負擔的增加、人們對預防霍亂疫情的興趣日益濃厚以及保護時間更長的新型口服疫苗的市場開拓。但低收入地區疫苗可近性不足、部分地區疫苗接種意識不高等因素持續在一定程度上限制市場潛力。從樂觀的角度來看，增加對尋找針對多種血清型提供交叉保護的疫苗的投資開闢新的途徑。製造商和國際組織之間為提高流行地區的可用性而建立的夥伴關係也將是未來幾年的一個有吸引力的機會。

本研究的主要特點

• 本報告對全球霍亂疫苗市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
• 揭示了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
• 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
• 本報告根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球霍亂疫苗市場的主要企業。
• 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
• 霍亂疫苗全球市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過用於分析全球霍亂疫苗市場的各種策略矩陣，促進相關人員的決策。

目錄

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章 市場動態、法規及趨勢分析

• 市場動態
  • 加強疫苗接種宣傳活動
  • 霍亂疫苗供不應求
  • 增加教育培訓項目
• 主要亮點
• 監管場景
• 市場趨勢
• 管道分析
• 產品發布/核准
• PEST分析
• 波特的分析
• 流行病學
• 治療流程（病人歷程）
• 治療方案分析
• 主要市場參與者的新投資
• 價格分析
• 疾病意識計劃
• 治療安全性和有效性分析
• 合併、收購和合作

第4章 全球霍亂疫苗市場 - 冠狀病毒（COVID-19）大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章 全球霍亂疫苗市場，依產品類型，2019-2031

• Vaxchora
• Dukoral
• ShanChol
• Euvichol-Plus/Euvichol
• 其他（後期疫苗等）

第6章 全球霍亂疫苗市場，依疫苗類型，2019-2031

• 去活化全細胞疫苗和重組霍亂毒素B疫苗
• 僅含有殺死的全細胞的疫苗
• 口服霍亂活病毒疫苗

第7章 全球霍亂疫苗市場，依病患類型，2019-2031

• 兒童
• 成人

第8章 全球霍亂疫苗市場，依通路，2019-2031

• 公共
• 私人

第9章 全球霍亂疫苗市場，依地區，2019-2031

• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 歐洲其他地區
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中部非洲
• 南非

第10章 競爭格局

• 公司簡介
  • Sanofi
  • Biovac.co.za.
  • EMERGENT
  • Celldex Therapeutics
  • Valneva SE
  • Hilleman Laboratories
  • Shanghai United Cell Biotechnology Co., Ltd（Hillhouse Capital）
  • PaxVax, Inc.
  • Astellas Pharma Inc.
  • EUBIOLOGICS CO., LTD.

第11章 章節

• 參考
• 調查方法
• 關於出版商

The global cholera vaccines market was valued US$ 82.5 Mn in 2023 and is expected to reach US$ 204.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 12% from 2024 to 2031.

Figure 1. Global Cholera Vaccines Market Share (%), By Region, 2023

Cholera is a bacterial disease that usually spreads through contaminated water. It causes severe diarrhea and dehydration and can be fatal within hours if left untreated. The disease is most prevalent in areas with inadequate water treatment, poor sanitation, and inadequate hygiene, such as Africa, Southeast Asia, and Haiti. The World Health Organization (WHO) and the UN Children's Fund (UNICEF) have warned that cholera is making a devastating comeback, particularly targeting vulnerable communities. The risk of a cholera epidemic is highest when poverty, war, or natural disasters force people to live in crowded conditions without adequate sanitation. Cholera is a disease of poverty, affecting people with inadequate access to safe water and basic sanitation. The infection is not likely to spread directly from one person to another; therefore, casual contact with an infected person is not a significant risk factor for becoming ill. In terms of prevention, a multifaceted approach is key to controlling cholera and reducing deaths. This includes ensuring access to safe water, adequate sanitation, and hygiene, as well as vaccination in high-risk areas.

Market Dynamics:

Key drivers favoring the growth of global cholera vaccines market include the rising burden of cholera disease globally, growing focus on preventing cholera outbreaks, and the development of novel oral vaccines with a longer duration of protection. However, factors such as insufficient access to vaccines in low-income regions, and a lack of awareness about immunization in certain communities continue to restrain the market potential to a certain extent. On the optimistic side, increasing investments in the research of vaccines providing cross-protection against multiple serotypes open up new avenues. Partnerships between makers and international organizations for improving availability in endemic areas also present attractive opportunities over the next few years.

Key features of the study:

• This report provides in-depth analysis of the global cholera vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global cholera vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies - Key companies covered as a part of this study include Sanofi, Biovac.co.za., EMERGENT, Celldex Therapeutics, Valneva SE, Hilleman Laboratories, Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital), PaxVax, Inc., Astellas Pharma Inc., and EUBIOLOGICS CO., LTD.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global cholera vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cholera vaccines market

Detailed Segmentation:

• Global Cholera Vaccines Market, By Product Type
  • Vaxchora
  • Dukoral
  • ShanChol
  • Euvichol-Plus/Euvichol
  • Others (Late Phase Vaccines, etc.)
• Global Cholera Vaccines Market, By Vaccine Type
  • Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
  • Killed Whole-cell Only Vaccines
  • Live Attenuated Oral Cholera Vaccine
• Global Cholera Vaccines Market, By Patient Type
  • Pediatric
  • Adults
• Global Cholera Vaccines Market, By Distribution Channel
  • Public
  • Private
• Global Cholera Vaccines Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in the Global Cholera Vaccines Market:
  • Sanofi
  • Biovac.co.za.
  • EMERGENT
  • Celldex Therapeutics
  • Valneva SE
  • Hilleman Laboratories
  • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
  • PaxVax, Inc.
  • Astellas Pharma Inc.
  • EUBIOLOGICS CO., LTD.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Vaccine Type
  • Market Snippet, By Patient Type
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increasing Vaccination Campaigns
  • Supply Shortage of Cholera Vaccine
  • Increasing Educational Training Programmes
• Key Highlights
• Regulatory Scenario
• Market Trends
• Pipeline Analysis
• Product Launch/Approval
• PEST Analysis
• PORTER's Analysis
• Epidemiology
• Treatment Algorithm (Patient Journey)
• Treatment Option Analysis
• New Investments by Major Market Players
• Pricing Analysis
• Disease Awareness Programs
• Treatment Safety and Efficacy Analysis
• Mergers, Acquisitions, and Collaborations

4. Global Cholera Vaccines Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Cholera Vaccines Market, By Product Type, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Vaxchora
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Dukoral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• ShanChol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Euvichol-Plus/Euvichol
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Others (Late Phase Vaccines, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

6. Global Cholera Vaccines Market, By Vaccine Type, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Killed Whole-cell and Recombinant Cholera Toxin B Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Killed Whole-cell Only Vaccines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Live Attenuated Oral Cholera Vaccine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

7. Global Cholera Vaccines Market, By Patient Type, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)

8. Global Cholera Vaccines Market, By Distribution Channel, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Public
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Mn)
• Private
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 201s9-2031,(US$ Mn)

9. Global Cholera Vaccines Market, By Region, 2019-2031, (US$ Mn)

• Introduction
  • Market Share Analysis, By Country, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Country, 2020 -2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Mn)
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profile
  • Sanofi
  • Biovac.co.za.
  • EMERGENT
  • Celldex Therapeutics
  • Valneva SE
  • Hilleman Laboratories
  • Shanghai United Cell Biotechnology Co., Ltd (Hillhouse Capital)
  • PaxVax, Inc.
  • Astellas Pharma Inc.
  • EUBIOLOGICS CO., LTD.
• Analyst Views

11. Section

• References
• Research Methodology
• About us